Location: ExCel London, United Kingdom
The Cellistic team is heading to Advanced Therapies 2026 in London, and we’re looking forward to meeting drug developers aiming to advance their immuno-oncology or regenerative medicine cell therapy programs.
If you’re seeking a path to GMP manufacturing with consistent, clinically meaningful yields, we’d welcome the chance to explore how our adaptable platforms, technologies and services can support your development goals.
Don't miss our presentation
March 17 • 5:00 PM
Join us as we explore how Cellistic’s iPSC-derived, allogeneic manufacturing platforms enable GMP-compliant production of diverse immune and non-immune cell types, advancing next-generation immuno-oncology and regenerative medicine cell therapies. We’ll share how our purpose-built approach—centered on modular, pre-built platforms and integrated technologies—helps developers reach clinical and commercial readiness with greater speed, consistency, and scalability.
Meet our team
We’ll be on site at ExCeL London for the full two days and are available for one-on-one conversations or relaxed coffee meetings. If you’d like to schedule time with us, feel free to signal your interest through the form below